Lofral

Lofral

amlodipine

Manufacturer:

Acino Switzerland

Distributor:

Ceutical Trading
Concise Prescribing Info
Contents
Amlodipine besylate
Indications/Uses
Essential HTN, MI or angina (unstable & vasospasm or Prinzmetal).
Dosage/Direction for Use
HTN Initially 2.5-10 mg daily. Maintenance: 5-10 mg daily. Angina pectoris Initially 5-10 mg daily. Maintenance: 10 mg daily.
Administration
May be taken with or without food.
Contraindications
Known hypersensitivity to dihydropyridines.
Special Precautions
Severe left ventricular dysfunction, obstructive hypertrophic cardiomyopathy, oedema, increased intracranial pressure. Elderly, hepatic impairment. Pregnancy & lactation.
Adverse Reactions
Peripheral oedema. Flushing, palpitations; headache, fatigue, dizziness, somnolence; dermatitis, rash, pruritus, urticaria; sexual dysfunction; cramps.
Drug Interactions
MIMS Class
Calcium Antagonists / Anti-Anginal Drugs
ATC Classification
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
Presentation/Packing
Form
Lofral tab 10 mg
Packing/Price
30's
Form
Lofral tab 5 mg
Packing/Price
30's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in